Each Tuesday, we reverse-engineer a real SaaS company's revenue, profit, CAC, funnels, and its top growth tactic.
Sign up to access all features
Sign up with GoogleSign up with LinkedInAlready have an account? Log in
GetLatka is trusted by 200k+ founders, researchers, and marketers.
No contracts, cancel at any time
Provider of a Web-based digital application designed to allow oncologists collect genetic information from cancer patients and compare that information against a large database of similar patients. The company's application helps patients and physicians to identify risk factors caused due to cancer, genetics and other oncological problem, enabling doctors to identify high-risk patients and offer preventative treatment.
Last updated
In 2024, CancerIQ's revenue reached $9.2M. The company previously reported $5.5M in 2023. Since its launch in 2013, CancerIQ has shown consistent revenue growth.
CancerIQ has not publicly disclosed its valuation. The company has raised $20M in total funding to date.
CancerIQ has raised $20M in total funding across 3 rounds, most recently a $14M Series B round in 2022.
| Year | Round | Amount | Valuation | % Sold | Source |
|---|---|---|---|---|---|
| 2022 | Series B | $14M | - | - | |
| 2020 | Series A | $4.8M | - | - | |
| 2014 | Convertible Note | $1.2M | - | - |
CEO
Founder and CEO at Cancer IQ Inc. Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively. Her journey with Cancer IQ began in 2012, when Feyi wanted to be more of a participant in the healthcare sector than a bystander. On a family trip to climb Mount Kilimanjaro, she hatched a plan to defer her position at McKinsey and commercialize the work of her mother, a renowned medical oncologist. While at University of Chicago Medicine, Feyi witnessed the most cutting edge clinical care, and identified a number of bottlenecks that constrained patient access to it. In 2013, CancerIQ was born. After recruiting a board of thought leading advisors spearheaded by her mother, she led the product design effort, raised capital, and recruited a team to help her flesh-out the concept. Since conceiving the concept, CancerIQ has garnered support from top accelerator programs, investors, and most importantly - customers. She leads the business development team at CancerIQ, and manages all strategic partnerships. She is a Chicago Booth New Venture Challenge winner, a Rock Health fellow, and winner of 1776’s Global Challenge Cup.
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
We do not have customer count information for CancerIQ yet.
CancerIQ employs approximately 39 people as of 2026, down from 46 in 2023, including 9 sales reps that carry a quota.
CancerIQ generates an estimated $9.2M in annual revenue.
CancerIQ was founded by Feyi Ayodele.
The CEO of CancerIQ is Feyi Ayodele.
CancerIQ raised $20M across 3 rounds.
CancerIQ has 39 employees.
CancerIQ is headquartered in United States.
CancerIQ operates across multiple industries. Browse revenue, funding, and growth data for CancerIQ in each sector below.
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profileQobra is an AI-first sales compensation platform founded in 2020 by Antoine Fort (CEO), Axel (CTO)...
Rocket.net is a managed WordPress hosting company founded in 2020 by Ben Gabler, who brings 25...
In-House Health is an AI-powered technical platform for modern nursing teams that transforms the...
85 associated members
2024 Revenue
$9.2M(Est.)
Funding
$20M
Team
39
Founded
2013
| Year | Milestone | Source |
|---|---|---|
| 2024 | CancerIQ Hit $9.2m revenue in October 2024 | Estimated |
| 2023 | CancerIQ Hit $5.5m revenue in November 2023 | Estimated |
| 2022 | CancerIQ Hit $4m revenue in November 2022 | |
| 2022 | CancerIQ Hit $4m revenue in March 2022 | |
| 2021 | CancerIQ Hit $1.7m revenue in November 2021 | |
| 2021 | CancerIQ Hit $1.7m revenue in April 2021 | |
| 2013 | Launched with $0 revenue |
| Year | Milestone | Source |
|---|---|---|
| 2024 | Reached 39 employees (December 2024) | |
| 2024 | Reached 37 employees (October 2024) | |
| 2023 | Reached 46 employees (November 2023) | |
| 2022 | Reached 33 employees (November 2022) | |
| 2022 | Reached 33 employees (March 2022) | |
| 2021 | Reached 20 employees (November 2021) | |
| 2021 | Reached 20 employees (April 2021) | |
| 2020 | Reached 18 employees (November 2020) |
If you're the CEO and would like to join the podcast, please DM Nathan Latka on LinkedIn.